共 50 条
- [21] Discovery of a nitroaromatic nannocystin with potent in vivo anticancer activity against colorectal cancer by targeting AKT1Acta Pharmacologica Sinica, 2024, 45 : 1044 - 1059Han ZhangFei XieXiao-ya YuanXin-tong DaiYun-feng TianMing-ming SunSi-qi YuJia-you CaiBin SunWei-cheng ZhangChang-liang Shan
- [22] An EGF receptor targeting Ranpirnase-diabody fusion protein mediates potent antitumour activity in vitro and in vivoCANCER LETTERS, 2015, 357 (01) : 364 - 373Kiesgen, StefanArndt, Michaela A. E.Koerber, ChristophArnold, UlrichWeber, TobiasHalama, NielsKeller, ArminBoetticher, BenediktSchlegelmilch, AnneLiebers, NoraCremer, MartinHerold-Mende, ChristelDyckhoff, GerhardFederspil, Philippe A.Jensen, Alexandra D.Jaeger, DirkKontermann, Roland E.Mier, WalterKrauss, Juergen
- [23] Discovery of a novel HDM2 inhibitor with potent in vivo anti-tumor activityCANCER RESEARCH, 2012, 72Wang, YaolinLipari, PhilipMirza, AsraLin, YinghuiZhang, RuminBogen, StephaneBogen, StephaneMa, YaoHicklin, Daniel J.Seidel-Dugan, CynthiaLiu, SuxingWang, XiaoyingDoll, RonaldShipps, GeraldBishop, Walter Robert
- [24] In vitro and in vivo activity of DHES0815A, an antibody-drug conjugate targeting HER2/neu in uterine serous carcinomaGYNECOLOGIC ONCOLOGY, 2021, 162 : S186 - S187Tymon-Rosario, JoanBonazzoli, ElenaGuglielmi, AdeleBellone, StefaniaNagarkatti, NupurZammataro, LucaZeybek, BurakHarold, JustinMauricio, DennisClark, MitchellAndikyan, VaagnHuang, GloriaAltwerger, GaryMenderes, GuldenAzodi, MasoudRatner, ElenaSchwartz, PeterSantin, Alessandro
- [25] Discovery of petroselinic acid with in vitro and in vivo antifungal activity by targeting fructose-1,6-bisphosphate aldolasePHYTOMEDICINE, 2024, 133Wang, Xin-RongZhong, HuaMa, Shan-ShanHuang, Ya-HuiXu, Wei-HengWang, Yan
- [26] HLA-DR-targeting tetrameric IFNα2b immunocytokine has potent in vitro and in vivo activity in myelomas, lymphomas and leukemiasCANCER RESEARCH, 2011, 71Rossi, EdmundRossi, DianeCardillo, ThomasStein, RhonaNair, AnjuZalath, MariaGoldenberg, DavidChang, Chien-Hsing
- [27] Remarkable in vitro and in vivo activity of IMGN853, an antibody-drug conjugate targeting folate receptor alpha linked to the tubulin-disrupting maytansinoid DM4, in biologically aggressive (type II) endometrial cancersGYNECOLOGIC ONCOLOGY, 2018, 149 : 70 - 70Altwerger, G.Bonazzoli, E.Bellone, S.Takata, T.Menderes, G.Pettinella, F.Bianchi, A.Riccio, F.Feinberg, J.Zammataro, L.Han, C.Yadav, G.Dugan, K. B.Morneault, A.Ponte, J.Buza, N.Hui, P.Litkouhi, B.Ratner, E. S.Silasi, D. A.Huang, G. S.Azodi, M.Schwartz, P. E.Santin, A. D.
- [28] In vitro and in vivo activity of DHES0815A, an antibody-drug conjugate targeting HER2/neu in uterine serous carcinoma.CANCER RESEARCH, 2021, 81 (13)Tymon-Rosario, Joan Tymon R.Bonazzoli, ElenaBellone, StefaniaManzano, AranchaManara, PaolaZammataro, LucaPelligra, SilviaGuglielmi, AdeleGnutti, BarbaraZeybek, BurakHarold, JustinMauricio, DennisRatner, ElenaSchwartz, PeterSantin, Alessandro D.
- [29] Discovery and characterization of a novel series of potent CXCR2 antagonists with improved in vivo activity.ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U62 - U62Palovich, MRWiddowson, KElliott, JDWhite, JRSarau, HMRutledge, MCBi, JDede, KABenson, GMGriswold, DEMartin, LDNie, HSchmidt, DMFoley, JJ
- [30] First in Human Phase 1/2a Study of PEN-221 Somatostatin Analog (SSA)-DM1 Conjugate for Patients (PTS) With Advanced Neuroendocrine Tumor (NET) or Small Cell Lung Cancer (SCLC): Phase 1 ResultsPANCREAS, 2019, 48 (03) : 436 - 437Halperin, Daniel M.Johnson, Melissa L.Meyer, TimFojo, Antonio TitoCook, NatalieBlaszkowsky, Lawrence S.Schlechter, Benjamin L.Chan, JenniferYao, James C.Jemiai, YannisKriksciukaite, KristinaMei, LauraShonukan, ToyinAlland, LeilaWooster, RichardKulke, Matthew H.